Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ

Gynecologic Oncology

Volumn 87, Issue 1, 2002, Pages 129-132

  Lea, Jayanthi S ^a   Shin, Christine H ^b   Sheets, Ellen E ^b   Coleman, Robert L ^a   Gehrig, Paola A ^c   Duska, Linda R ^d   Miller, David S ^a   Schorge, John O ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cervical adenocarcinoma; Endocervical curettage; Uterine preservation

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CURETTAGE; DIAGNOSTIC VALUE; ELECTROSURGERY; EXCISION; FEMALE; FEMALE FERTILITY; HISTOLOGY; HUMAN; HYSTERECTOMY; MEDICAL RECORD; NULLIPARA; PREDICTION; PRIORITY JOURNAL; RECURRENT CANCER; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CONIZATION;

EID: 0036920003     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6791     Document Type: Article

References (16)

1. Plaxe SC, Saltztein SL. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening. Gynecol Oncol 1999;75:55-61.
2. Lee KR, Flynn CE. Early invasive adenocarcinoma of the cervix. Cancer 2000;89:1048-55.
3. Poynor EA, Barakat RR, Hoskins WJ. Management and follow-up of patients with adenocarcinoma-in-situ of the uterine cervix. Gynecol Oncol 1995;57:158-64.
4. Kennedy AW, EITabbakh GH, Biscotti CV, Wirth S. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ. Gynecol Oncol 1995;58:274-7.
5. Shin CH, Schorge JO, Lee KR, Sheets EE. Conservative management of adenocarcinoma in situ of the cervix. Gynecol Oncol 2000;79:6-10.
6. Hopkins MP, Roberts JA, Schmidt RW. Cervical adenocarcinoma in situ. Obstet Gynecol 1988;71:842-4.
7. Hopkins M. Adenocarcinoma in situ of the cervix - The margins must be clear. Gynecol Oncol 2000;79:4-5.
8. Ostor AG, Duncan A, Quinn M, Rome R. Adenocarcinoma in situ of the uterine cervix: An experience with 100 cases. Gynecol Oncol 2000;79:207-10.
9. Hocking GR, Haymen JA, Ostor AG. Adenocarcinoma in situ of the cervix progressing to invasive adenocarcinoma. Aust N Z J Obstet Gynaecol 1996;36:218-20.
10. Kashimura M, Shinora M, Oikawa K, Hamasaki K, Sato H. An adenocarcinoma in situ of the cervix that developed into invasive adenocarcinoma after 5 years. Gynecol Oncol 1990;36:128-33.
11. Muntz HG. Can cervical adenocarcinoma in situ be safely managed by conization alone? Gynecol Oncol 1996;61:301-3.
12. Etherington IJ, Luesley DM. Adenocarcinoma in situ of the cervix: Controversies in diagnosis and treatment. J Lower Gen Tract Dis 2001;5:94-8.
13. Denehy TR, Gregori CA, Breen JL. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 1999; 90:1-6.
14. Azodi M. Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT. Adenocarcinoma in situ of the cervix: Management and outcome. Gynecol Oncol 1999;73:348-53.
15. Goldstein NS, Mani A. The status and distance of cone biopsy margins as a predictor for excision adequacy for endocervical adenocarcinoma in situ. Am J Clin Pathol 1998;109:727-32.
16. Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF. Adenocarcinoma in situ of the cervix: Significance of cone biopsy margins. Obstet Gynecol 1996;88:82-6.